Функціональна активність наднирникових залоз та індекс абдомінального ожиріння як маркери дисліпідемії у хворих на цукровий діабет 2 типу
DOI:
https://doi.org/10.15587/2313-8416.2015.52261Słowa kluczowe:
ожиріння, цукровий діабет 2 типу, кортикостероїди, кортизол, ДГЕА, індекс вісцерального ожиріння, дисліпідеміяAbstrakt
У наведеній роботі обґрунтована доцільність визначення індексу вісцерального ожиріння як маркеру порушення ліпідного обміну, а також дисбалансу кортикостероїдів, зокрема співвідошення кортизол / ДГЕА у хворих на цукровий діабет 2 типу. Встановлено гіперглікемічний та дисліпідемічний вплив підвищеної концентрації кортизолу та недостатнього вмісту дегідроепіандростерону (ДГЕА) у сироватці крові залежно від показника індексу вісцерального ожиріння
Bibliografia
Geetha, L., Deepa, M., Anjana, R. M., Mohan, V. (2011). Prevalence and Clinical Profile of Metabolic Obesity and Phenotypic Obesity in Asian Indians. Journal of Diabetes Science and Technology, 5 (2), 439–446. doi: 10.1177/193229681100500235
Reaven, G. M. (1988). Banting lecture 1988. Role of insulin resistance in human disease. Diabetes, 37 (12), 1595–1607. doi: 10.2337/diabetes.37.12.1595
Savineau, J.-P., Marthan, R., Dumas de la Roque, E. (2013). Role of DHEA in cardiovascular diseases. Biochemical Pharmacology, 85 (6), 718–726. doi: 10.1016/j.bcp.2012.12.004
Tchernof, A., Labrie, F. (2004). Dehydroepiandrosterone, obesity and cardiovascular disease risk: a review of human studies. European Journal of Endocrinology, 151 (1), 1–14. doi: 10.1530/eje.0.1510001
Traish, A. M., Kang, H. P., Saad, F., Guay, A. T. (2011). Dehydroepiandrosterone (DHEA)-A Precursor Steroid or an Active Hormone in Human Physiology (CME). The Journal of Sexual Medicine, 8 (11), 2960–2982. doi: 10.1111/j.1743-6109.2011.02523.x
Phillips, A. C., Carroll, D., Gale, C. R., Lord, J. M., Arlt, W., Batty, G. D. (2010). Cortisol, DHEA sulphate, their ratio, and all-cause and cause-specific mortality in the Vietnam Experience Study. European Journal of Endocrinology, 163(2), 285–292. doi: 10.1530/eje-10-0299
Djurhuus, C. B., Gravholt, C. H., Nielsen, S., Mengel, A., Christiansen, J. S., Schmitz, O. E., Møller, N. (2002). Effects of cortisol on lipolysis and regional interstitial glycerol levels in humans. American Journal of Physiology – Endocrinology And Metabolism, 283 (1), E172–E177. doi: 10.1152/ajpendo.00544.2001
Gross, K. L., Cidlowski, J. A. (2008). Tissue-specific glucocorticoid action: a family affair. Trends in Endocrinology & Metabolism, 19 (9), 331–339. doi: 10.1016/j.tem.2008.07.009
Hughes, K. A., Manolopoulos, K. N., Iqbal, J., Cruden, N. L., Stimson, R. H., Reynolds, R. M. et. al (2012). Recycling Between Cortisol and Cortisone in Human Splanchnic, Subcutaneous Adipose, and Skeletal Muscle Tissues In Vivo. Diabetes, 61 (6), 1357–1364. doi: 10.2337/db11-1345
Kollind, M., Adamson, U., Lins, P., Efendic, S. (1987). Diabetogenic Action of GH and Cortisol in Insulin-Dependent Diabetes Mellitus Aspects of the Mechanisms Behind the Somogyi Phenomenon. Hormone and Metabolic Research, 19 (04), 156–159. doi: 10.1055/s-2007-1011766
Whitworth, J. A., Mangos, G. J., Kelly, J. J. (2000). Cushing, Cortisol, and Cardiovascular Disease. Hypertension, 36 (5), 912–916. doi: 10.1161/01.hyp.36.5.912
Lefebvre, P. (2006). Sorting out the roles of PPAR in energy metabolism and vascular homeostasis. Journal of Clinical Investigation, 116 (3), 571–580. doi: 10.1172/jci27989
Semple, R. K. (2006). PPAR and human metabolic disease. Journal of Clinical Investigation, 116 (3), 581–589. doi: 10.1172/jci28003
Unger, R. H. (2001). Diseases of liporegulation: new perspective on obesity and related disorders. The FASEB Journal, 15 (2), 312–321. doi: 10.1096/fj.00-0590
Samaras, N., Samaras, D., Frangos, E., Forster, A., Philippe, J. (2013). A Review of Age-Related Dehydroepiandrosterone Decline and Its Association with Well-Known Geriatric Syndromes: Is Treatment Beneficial? Rejuvenation Research, 16 (4), 285–294. doi: 10.1089/rej.2013.1425
Davis, S. R., Shah, S. M., McKenzie, D. P., Kulkarni, J., Davison, S. L., Bell, R. J. (2008). Dehydroepiandrosterone Sulfate Levels Are Associated with More Favorable Cognitive Function in Women. The Journal of Clinical Endocrinology & Metabolism, 93 (3), 801–808. doi: 10.1210/jc.2007-2128
Weiss, E., Villareal, D. T., Fontana, L., Han, D.-H., Holloszy, J. O. (2011). Dehydroepiandrosterone (DHEA) replacement decreases insulin resistance and lowers inflammatory cytokines in aging humans. Aging, 3 (5), 533–542.
Bao, A.-M., Meynen, G., Swaab, D. F. (2008). The stress system in depression and neurodegeneration: Focus on the human hypothalamus. Brain Research Reviews, 57 (2), 531–553. doi: 10.1016/j.brainresrev.2007.04.005
McNelis, J. C., Manolopoulos, K. N., Gathercole, L. L., Bujalska, I. J., Stewart, P. M., Tomlinson, J. W., Arlt, W. (2013). Dehydroepiandrosterone exerts antiglucocorticoid action on human preadipocyte proliferation, differentiation, and glucose uptake. AJP: Endocrinology and Metabolism, 305 (9), E1134–E1144. doi: 10.1152/ajpendo.00314.2012
Ohlsson, C., Labrie, F., Barrett-Connor, E., Karlsson, M. K., Ljunggren, Ö., Vandenput, L. et. al (2010). Low Serum Levels of Dehydroepiandrosterone Sulfate Predict All-Cause and Cardiovascular Mortality in Elderly Swedish Men. The Journal of Clinical Endocrinology & Metabolism, 95 (9), 4406–4414. doi: 10.1210/jc.2010-0760
Barrett-Connor, E., von Mühlen, D., Laughlin, G. A., Kripke, A. (1999). Endogenous Levels of Dehydroepiandrosterone Sulfate, but Not Other Sex Hormones, Are Associated with Depressed Mood in Older Women: The Rancho Bernardo Study. Journal of the American Geriatrics Society, 47 (6), 685–691. doi: 10.1111/j.1532-5415.1999.tb01590.x
Fukui, M., Kitagawa, Y., Ose, H., Hasegawa, G., Yoshikawa, T., Nakamura, N. (2007). Role of Endogenous Androgen Against Insulin Resistance and Athero-sclerosis in Men with Type 2 Diabetes. Current Diabetes Reviews, 3 (1), 25–31. doi: 10.2174/157339907779802094
Amato, M. C., Giordano, C., Galia, M., Criscimanna, A., Vitabile, S., Midiri, M., Galluzzo, A. (2010). Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care, 33 (4), 920–922. doi: 10.2337/dc09-1825
Petta, S., Amato, M., Cabibi, D., Cammà, C., Di Marco, V., Giordano, C. et. al (2010). Visceral adiposity index is associated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology, 52 (5), 1543–1552. doi: 10.1002/hep.23859
Andrews, R. C., Herlihy, O., Livingstone, D. E. W., Andrew, R., Walker, B. R. (2002). Abnormal Cortisol Metabolism and Tissue Sensitivity to Cortisol in Patients with Glucose Intolerance. The Journal of Clinical Endocrinology & Metabolism, 87 (12), 5587–5593. doi: 10.1210/jc.2002-020048
Apostolova, G. (2004). Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue. AJP: Endocrinology and Metabolism, 288 (5), E957–E964. doi: 10.1152/ajpendo.00442.2004
##submission.downloads##
Opublikowane
Numer
Dział
Licencja
Copyright (c) 2015 Олеся Вадимівна Корпачева-Зінич
Utwór dostępny jest na licencji Creative Commons Uznanie autorstwa 4.0 Międzynarodowe.
Our journal abides by the Creative Commons CC BY copyright rights and permissions for open access journals.
Authors, who are published in this journal, agree to the following conditions:
1. The authors reserve the right to authorship of the work and pass the first publication right of this work to the journal under the terms of a Creative Commons CC BY, which allows others to freely distribute the published research with the obligatory reference to the authors of the original work and the first publication of the work in this journal.
2. The authors have the right to conclude separate supplement agreements that relate to non-exclusive work distribution in the form in which it has been published by the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
